ARTICLE
TITLE

A randomised clinical trial comparing the outcome of trabeculectomy using triangular versus rectangular scleral flaps

SUMMARY

Background: Trabeculectomy is the standard surgical procedure for management of glaucoma. Objective: To compare the outcome of triangular and rectangular scleral flaps in trabeculectomy. Materials and methods: This study was carried out in the Department of Ophthalmology, BPKIHS, Dharan, over a period of one year. A total of 22 patients undergoing trabeculectomy were randomized to undergo either trabeculectomy with triangular scleral flap (Group A= 11 eyes) or trabeculectomy with rectangular flap (Group B =11 eyes). Outcome measurement: The parameters studied were intraocular pressure (IOP), anterior chamber depth (ACD), bleb characteristics and surgical complications. Statistics: P value of <0.05 was considered significant. All calculations were executed using SPSS 11.0 software program. Results: The age ranged between 40 to 76 years with the mean of 56.5±9.25 years. The most common preoperative diagnosis was angle closure glaucoma. The postoperative percentage of IOP reduction (Group A=68.9%; Group B=66.51%) was statically significant in both the groups (p=0.001). Trabeculectomy was almost equally effective with complete surgical success of 91% in group A, and 82% in group B (p=0.534). Final bleb scores were almost similar in both the groups with 3.27 ± 1.5 in group A and 3.36±1.21 in group B (p=0.877). Hypotony with the IOP less than 6 mmHg was found in the first post-operative day in 2 patients in Group A and in 1 in Group B. All of them improved spontaneously within a week. Conclusion: Both triangular and rectangular scleral flaps in trabeculectomy are equally effective in terms of post surgical IOP control, bleb characteristics and complications. Keywords: Trabeculectomy; glaucoma; intra ocular pressure; scleral flap DOI: 10.3126/nepjoph.v1i1.3669 Nep J Oph 2009;1(1):20-24

 Articles related

Thomas SJ Crabtree,Ralph A DeFronzo,Robert E J Ryder,Clifford J Bailey    

Imeglimin is a novel, first in-class, blood glucose-lowering agent which acts via a mitochondrial mechanism to enhance glucose-induced insulin secretion, decrease hepatic glucose output and increase glucose uptake by skeletal muscle. A systematic review ... see more


Marshall J Heradien,Pieter van der Bijl,Paul A Brink    

Hypertension is a global health issue of paramount importance, which has not spared the African continent where an unacceptably high prevalence of uncontrolled blood pressure prevails among its population. Renal denervation (RD) represents an invasive ma... see more


Syed M R Gillani,Alan M Nevill,Baldev M Singh    

Background: Patient activation is a demonstration of people participating effectively in their own care as measurable in objective outcomes. Techniques of activating patients are various. Aims: We developed a structured information booklet to promote pat... see more


Catherine W. Gathu,Jacob Shabani,Nancy Kunyiha,Riaz Ratansi    

AbstractBackground: Diabetes self-management education (DSME) is a key component of diabetes care aimed at delaying complications. Unlike usual care, DSME is a more structured educational approach provided by trained, certified diabetes educators (C... see more


Jesca M. Batidzirai    

AbstractRandomisation is an integral component of any sensible clinical trial. Randomisation is the only way we can be sure that the patients have been allocated into the treatment arms with as minimum bias as possible, and that the treatment arms are si... see more